1. Home
  2. BNED vs GOSS Comparison

BNED vs GOSS Comparison

Compare BNED & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNED
  • GOSS
  • Stock Information
  • Founded
  • BNED 1965
  • GOSS 2015
  • Country
  • BNED United States
  • GOSS United States
  • Employees
  • BNED N/A
  • GOSS N/A
  • Industry
  • BNED Other Specialty Stores
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNED Consumer Discretionary
  • GOSS Health Care
  • Exchange
  • BNED Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • BNED 295.2M
  • GOSS 347.8M
  • IPO Year
  • BNED N/A
  • GOSS 2019
  • Fundamental
  • Price
  • BNED $8.43
  • GOSS $2.45
  • Analyst Decision
  • BNED
  • GOSS Strong Buy
  • Analyst Count
  • BNED 0
  • GOSS 4
  • Target Price
  • BNED N/A
  • GOSS $8.50
  • AVG Volume (30 Days)
  • BNED 296.7K
  • GOSS 3.0M
  • Earning Date
  • BNED 09-09-2025
  • GOSS 08-05-2025
  • Dividend Yield
  • BNED N/A
  • GOSS N/A
  • EPS Growth
  • BNED N/A
  • GOSS N/A
  • EPS
  • BNED N/A
  • GOSS N/A
  • Revenue
  • BNED $1,567,800,000.00
  • GOSS $40,237,000.00
  • Revenue This Year
  • BNED $2.74
  • GOSS N/A
  • Revenue Next Year
  • BNED N/A
  • GOSS $30.65
  • P/E Ratio
  • BNED N/A
  • GOSS N/A
  • Revenue Growth
  • BNED N/A
  • GOSS N/A
  • 52 Week Low
  • BNED $7.90
  • GOSS $0.66
  • 52 Week High
  • BNED $14.41
  • GOSS $2.64
  • Technical
  • Relative Strength Index (RSI)
  • BNED 45.86
  • GOSS 71.91
  • Support Level
  • BNED $8.24
  • GOSS $1.88
  • Resistance Level
  • BNED $8.77
  • GOSS $2.65
  • Average True Range (ATR)
  • BNED 0.32
  • GOSS 0.14
  • MACD
  • BNED 0.12
  • GOSS 0.04
  • Stochastic Oscillator
  • BNED 77.47
  • GOSS 85.81

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is an operator of bookstores in college and university campuses across the United States. The company is also engaged in providing digital education services. It operates in three reportable segments that include Retail offers existing and prospective clients the flexibility of physical, virtual, or custom store solutions, and wholesale is comprised of the wholesale and virtual retail fulfillment, and support operations of the MBS subsidiary, also Corporate Services represent unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources. It earns majority of the revenue from Retail segment.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: